Scott M. Plesha
CEO and President, Director · Pelthos Therapeutics Inc.
Individual
- 2025
- Apr 1, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott M. Plesha files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd C. Davis - $1000K in PTHS purchases and sales in the last 12 months
- Ezra M. Friedberg - $326K in PTHS purchases and sales in the last 12 months
- Peter Greenleaf - $54K in PTHS purchases and sales in the last 12 months
- Matthew Pauls - $54K in PTHS purchases and sales in the last 12 months
- Knuettel Francis II - $40K in PTHS purchases and sales in the last 12 months
- Richard Malamut - $12K in PTHS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott M. Plesha?
Scott M. Plesha is a corporate insider, tracked as CEO and President, Director of Pelthos Therapeutics Inc. (PTHS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Scott M. Plesha last file a Form 4?
The most recent primary Form 4 on record is dated 1 April 2026, one of 2 filings going back to 2025.
